Reuters spoke to three-dozen people inside the industry including retailers, drugmakers, telehealth providers and investors to show how the weight-loss sector is shifting to better meet consumers ...

Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: ...

Health‑advertising researcher Erin Willis at the University of Colorado-Boulder said consumers are now bombarded with GLP-1 ...

Colchicine is a drug that reduces swelling and inflammation in the body. Inflammation is one of the main reasons why ...

News you should know, including a really big Powerball jackpot; a salmonella outbreak linked to oysters; and more!

Novo Nordisk receives FDA approval for its oral weight-loss pill. Analyst says NVO stock might now have an edge over Eli Lilly.

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

In a landmark development Monday, the Food and Drug Administration green-lit an oral version of the Novo Nordisk obesity ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...